Glucose-galactose malabsorption (GGM) is a rare inherited metabolic disorder that prevents the body from absorbing two simple sugars: glucose and galactose. Glucose-galactose malabsorption (GGM) is a ...
Glucose-galactose malabsorption (GGM) is a rare metabolic condition. It occurs when a genetic variation makes the body unable to properly absorb the simple sugars glucose and galactose. Sugars are the ...
We describe a 55-year-old man with the cardiac variant of Fabry's disease who had residual α-galactosidase A activity as the result of a missense mutation encoding a substitution of arginine for ...
There’s no conspiracy among mothers. Across all species, mothers stop producing milk when the job is done. Growth slows, and the sugar supply shuts off… Just because we can digest milk doesn’t mean we ...
Galactosemia is a genetic disorder in which the body cannot process galactose, which is a simple sugar that is found in many foods. It is actually part of the sugar called lactose, (lactose contains ...
A research study demonstrates in mice the biological relevance of sex in the effects of accelerated ageing caused by a chronic treatment of D-galactose, a sugar found abundantly in milk and to a ...
CAMBRIDGE, Mass., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs, ...
Cetuximab, a chimeric mouse–human IgG1 monoclonal antibody against the epidermal growth factor receptor, is approved for use in colorectal cancer and squamous-cell carcinoma of the head and neck. A ...
In our opinion the article by Van Tine et al 1 highlights the importance of testing for anti–Gal antibodies in patients who are potential candidates for treatment with mAbs, particularly cetuximab.